| NCT ID | NCT05918601 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Health-risk Behaviours |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-06-30 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-06-30 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Aim: To test the effectiveness of a peer-led personalized support program using instant messaging applications and a self- determination theory-based intervention to help young drug abusers quit drugs. Hypothesis to be tested: The investigators hypothesize that compared with those in the control group, the participants in the intervention group will experience greater success in reducing and quitting drugs and will have a better health-related quality of life at 12 months follow-up.
Eligibility Criteria
The inclusion criteria of target service group (drug abusers) for this programme: * be aged 35 or below * be able to communicate in Cantonese * have an history of drug abuse within the past 12 months (including all types of drugs such as narcotics analgesics, hallucinogens, depressants, stimulants, tranquillizers and other recreational drugs) The exclusion Criteria of target service group (drug abusers) for this programme: * psychologically or physically unable to communicate The inclusion criteria of peer supporters: * be aged 18 - 35 * be able to communicate in Cantonese * have a medical background * complete the training courses and pass the evaluation of peer supporter qualification The exclusion Criteria of peer supporters: * psychologically or physically unable to communicate
Contact & Investigator
Ho Cheung William Li
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT05918601 clinical trial?
This trial is open to participants of all sexes, studying Health-risk Behaviours. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05918601 currently recruiting?
Yes, NCT05918601 is actively recruiting participants. Contact the research team at williamli@cuhk.edu.hk for enrollment information.
Where is the NCT05918601 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT05918601 clinical trial?
NCT05918601 is sponsored by Chinese University of Hong Kong. The principal investigator is Ho Cheung William Li at Chinese University of Hong Kong. The trial plans to enroll 200 participants.